Ost-müük BioCryst - BCRX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.07 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 8.48 |
Avatud* | 8.42 |
Aastane muutus* | -47.11% |
Päeva ulatus* | 8.35 - 8.51 |
52 nädala ulatus | 7.61-18.00 |
Keskmine maht (10 päeva) | 2.84M |
Keskmine maht (3 kuud) | 61.63M |
Turukapitalisatsioon | 1.60B |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 188.45M |
Tulu | 270.83M |
EPS | -1.33 |
Dividendid (% kasumist) | N/A |
Beeta | 2.03 |
Järgmine tuluaruande kuupäev | May 3, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Mar 27, 2023 | 8.44 | -0.03 | -0.35% | 8.47 | 8.53 | 8.34 |
Mar 24, 2023 | 8.48 | 0.36 | 4.43% | 8.12 | 8.53 | 8.07 |
Mar 23, 2023 | 8.09 | 0.15 | 1.89% | 7.94 | 8.28 | 7.91 |
Mar 22, 2023 | 7.90 | -0.15 | -1.86% | 8.05 | 8.20 | 7.89 |
Mar 21, 2023 | 8.13 | 0.14 | 1.75% | 7.99 | 8.20 | 7.91 |
Mar 20, 2023 | 7.97 | -0.10 | -1.24% | 8.07 | 8.10 | 7.91 |
Mar 17, 2023 | 8.05 | 0.01 | 0.12% | 8.04 | 8.15 | 7.97 |
Mar 16, 2023 | 8.14 | -0.07 | -0.85% | 8.21 | 8.40 | 8.13 |
Mar 15, 2023 | 8.34 | 0.21 | 2.58% | 8.13 | 8.57 | 8.12 |
Mar 14, 2023 | 8.29 | -0.14 | -1.66% | 8.43 | 8.57 | 8.22 |
Mar 13, 2023 | 8.29 | 0.11 | 1.34% | 8.18 | 8.51 | 8.15 |
Mar 10, 2023 | 8.26 | 0.11 | 1.35% | 8.15 | 8.27 | 7.79 |
Mar 9, 2023 | 8.17 | -0.32 | -3.77% | 8.49 | 8.60 | 8.06 |
Mar 8, 2023 | 8.52 | -0.08 | -0.93% | 8.60 | 8.65 | 8.36 |
Mar 7, 2023 | 8.63 | -0.19 | -2.15% | 8.82 | 8.87 | 8.62 |
Mar 6, 2023 | 8.81 | 0.07 | 0.80% | 8.74 | 8.81 | 8.64 |
Mar 3, 2023 | 8.75 | -0.13 | -1.46% | 8.88 | 8.91 | 8.71 |
Mar 2, 2023 | 8.81 | 0.15 | 1.73% | 8.66 | 8.87 | 8.59 |
Mar 1, 2023 | 8.79 | -0.04 | -0.45% | 8.83 | 8.90 | 8.60 |
Feb 28, 2023 | 8.81 | -0.17 | -1.89% | 8.98 | 9.10 | 8.74 |
BioCryst Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 270.827 | 157.17 | 17.812 | 48.835 | 20.653 |
Tulu | 270.827 | 157.17 | 17.812 | 48.835 | 20.653 |
Kulud, Kokku | 6.594 | 7.264 | 1.676 | 4.101 | 0.471 |
Brutokasum | 264.233 | 149.906 | 16.136 | 44.734 | 20.182 |
Kogu tegevuskulu | 419.262 | 279.052 | 194.58 | 148.29 | 114.873 |
Müük/Üldine/admin kulud, kokku | 159.371 | 118.818 | 67.929 | 37.121 | 13.614 |
Uuringud ja arendus | 253.297 | 208.808 | 122.964 | 107.068 | 84.888 |
Tulud majandustegevusest | -148.435 | -121.882 | -176.768 | -99.455 | -94.22 |
Intressitulud (kulu), muud tulud, neto | -95.948 | -59.927 | -6.046 | -9.442 | -7.032 |
Netotulu enne makse | -244.383 | -181.809 | -182.814 | -108.897 | -101.252 |
Netotulu pärast makse | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Netotulu enne erikulusid | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Netotulu | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Arvestatav tulu, v a erikulud | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Arvestatav tulu, koos erikuludega | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Jaotamisele kuuluv netotulu | -247.116 | -184.062 | -182.814 | -108.897 | -101.252 |
Keskmine jaotamisele kuuluv aktsia kohta | 185.908 | 179.117 | 167.267 | 115.6 | 103.185 |
Jaotatav EPS, v a erakorralised kulud | -1.32924 | -1.02761 | -1.09295 | -0.94202 | -0.98127 |
Dividends per Share - Common Stock Primary Issue | |||||
Jaotamisele kuuluv normaal-EPS | -1.32924 | -1.23024 | -1.08092 | -0.94202 | -0.82717 |
Erakorralised kulud kokku | |||||
Ootamatud kulutused (tulu) | 0 | -55.838 | 2.011 | 15.9 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 79.545 | 75.827 | 65.532 | 49.923 | 47.158 |
Tulu | 79.545 | 75.827 | 65.532 | 49.923 | 47.158 |
Kulud, Kokku | 2.496 | 3.613 | 0.247 | 0.238 | 0.419 |
Brutokasum | 77.049 | 72.214 | 65.285 | 49.685 | 46.739 |
Kogu tegevuskulu | 125.856 | 93.272 | 100.254 | 99.88 | 43.497 |
Müük/Üldine/admin kulud, kokku | 50.153 | 36.919 | 38.017 | 34.282 | 35.387 |
Uuringud ja arendus | 73.207 | 52.74 | 61.99 | 65.36 | 63.529 |
Tulud majandustegevusest | -46.311 | -17.445 | -34.722 | -49.957 | 3.661 |
Intressitulud (kulu), muud tulud, neto | -25.154 | -23.553 | -23.281 | -23.96 | -19.187 |
Netotulu enne makse | -71.465 | -40.998 | -58.003 | -73.917 | -15.526 |
Netotulu pärast makse | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Netotulu enne erikulusid | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Netotulu | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Arvestatav tulu, v a erikulud | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Arvestatav tulu, koos erikuludega | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Jaotamisele kuuluv netotulu | -71.541 | -42.52 | -58.859 | -74.196 | -17.779 |
Keskmine jaotamisele kuuluv aktsia kohta | 186.934 | 186.18 | 185.605 | 184.898 | 181.871 |
Jaotatav EPS, v a erakorralised kulud | -0.38271 | -0.22838 | -0.31712 | -0.40128 | -0.09776 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.38271 | -0.22838 | -0.31712 | -0.40128 | -0.29732 |
Ootamatud kulutused (tulu) | 0 | -55.838 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 566.136 | 323.8 | 164.345 | 114.352 | 125.391 |
Raha ja lühiajalised investeeringud | 507.601 | 300.366 | 136.226 | 104.467 | 114.397 |
Raha ja ekvivalendid | 504.389 | 272.127 | 114.172 | 26.731 | 50.282 |
Lühiajalised investeeringud | 3.212 | 28.239 | 22.054 | 77.736 | 64.115 |
Laekumata arved, neto | 29.413 | 8.646 | 22.146 | 4.293 | 6.117 |
Accounts Receivable - Trade, Net | 29.413 | 8.646 | 22.146 | 4.293 | 6.117 |
Total Inventory | 15.791 | 7.039 | 0 | 1.649 | |
Prepaid Expenses | 9.986 | 5.528 | 4.422 | 2.39 | 1.381 |
Other Current Assets, Total | 3.345 | 2.221 | 1.551 | 1.553 | 3.496 |
Total Assets | 588.151 | 334.715 | 175.282 | 146.841 | 178.259 |
Property/Plant/Equipment, Total - Net | 15.186 | 10.915 | 10.937 | 9.135 | 9.546 |
Property/Plant/Equipment, Total - Gross | 25.925 | 20.892 | 18.911 | 15.23 | 14.873 |
Accumulated Depreciation, Total | -10.739 | -9.977 | -7.974 | -6.095 | -5.327 |
Long Term Investments | 6.829 | 0 | 22.376 | 41.295 | |
Other Long Term Assets, Total | 0.978 | 2.027 | |||
Total Current Liabilities | 103.718 | 105.654 | 92.335 | 69.477 | 74.836 |
Accounts Payable | 27.808 | 18.713 | 13.988 | 7.769 | 6.337 |
Accrued Expenses | 74.489 | 56.791 | 37.646 | 27.739 | 24.794 |
Notes Payable/Short Term Debt | 0 | 30 | 29.561 | 29.121 | 28.682 |
Other Current Liabilities, Total | 1.421 | 0.15 | 2.12 | 0.221 | 8.484 |
Total Liabilities | 695.137 | 353.977 | 137.03 | 97.606 | 94.492 |
Total Long Term Debt | 585.457 | 244.452 | 41.289 | 28.075 | 19.501 |
Long Term Debt | 585.457 | 244.452 | 41.289 | 25.372 | 16.75 |
Capital Lease Obligations | 2.703 | 2.751 | |||
Other Liabilities, Total | 5.962 | 3.871 | 3.406 | 0.054 | 0.155 |
Total Equity | -106.986 | -19.262 | 38.252 | 49.235 | 83.767 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 1.843 | 1.769 | 1.541 | 1.101 | 0.984 |
Additional Paid-In Capital | 1098.5 | 1002.41 | 877.3 | 780.4 | 714.869 |
Retained Earnings (Accumulated Deficit) | -1207.5 | -1023.44 | -840.628 | -731.969 | -631.843 |
Other Equity, Total | 0.177 | 0.003 | 0.039 | -0.297 | -0.243 |
Total Liabilities & Shareholders’ Equity | 588.151 | 334.715 | 175.282 | 146.841 | 178.259 |
Total Common Shares Outstanding | 184.35 | 176.883 | 154.082 | 110.063 | 98.411 |
Current Port. of LT Debt/Capital Leases | 0 | 9.02 | 4.627 | 6.539 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 511.714 | 566.136 | 252.743 | 265.802 | 273.771 |
Raha ja lühiajalised investeeringud | 443.468 | 507.601 | 199.597 | 218.428 | 240.356 |
Raha ja ekvivalendid | 395.504 | 504.389 | 199.597 | 210.314 | 226.902 |
Lühiajalised investeeringud | 47.964 | 3.212 | 0 | 8.114 | 13.454 |
Laekumata arved, neto | 36.415 | 29.413 | 26.212 | 27.62 | 18.386 |
Accounts Receivable - Trade, Net | 36.415 | 29.413 | 26.212 | 27.62 | 18.386 |
Total Inventory | 16.144 | 15.791 | 13.663 | 9.846 | 5.113 |
Prepaid Expenses | 12.333 | 9.986 | 8.975 | 5.56 | 5.908 |
Other Current Assets, Total | 3.354 | 3.345 | 4.296 | 4.348 | 4.008 |
Total Assets | 527.72 | 588.151 | 265.763 | 277.284 | 284.431 |
Property/Plant/Equipment, Total - Net | 16.006 | 15.186 | 13.02 | 11.482 | 10.66 |
Property/Plant/Equipment, Total - Gross | 9.098 | 7.519 | 5.924 | 6.565 | |
Accumulated Depreciation, Total | -3.019 | -2.626 | -2.328 | -2.111 | -2.94 |
Total Current Liabilities | 81.017 | 103.718 | 133.608 | 115.601 | 101.201 |
Accounts Payable | 13.881 | 27.808 | 19.693 | 10.087 | 13.529 |
Accrued Expenses | 65.665 | 74.489 | 83.313 | 74.963 | 57.267 |
Notes Payable/Short Term Debt | 0 | 0 | 30 | 30 | 30 |
Other Current Liabilities, Total | 1.471 | 1.421 | 0.602 | 0.551 | 0.405 |
Total Liabilities | 691.935 | 695.137 | 412.807 | 383.359 | 359.419 |
Total Long Term Debt | 604.461 | 585.457 | 274.164 | 263.658 | 254.335 |
Long Term Debt | 604.461 | 585.457 | 274.164 | 263.658 | 254.335 |
Other Liabilities, Total | 6.457 | 5.962 | 5.035 | 4.1 | 3.883 |
Total Equity | -164.215 | -106.986 | -147.044 | -106.075 | -74.988 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 1.856 | 1.843 | 1.798 | 1.787 | 1.777 |
Additional Paid-In Capital | 1115.44 | 1098.5 | 1040.77 | 1022.97 | 1010.78 |
Retained Earnings (Accumulated Deficit) | -1281.7 | -1207.5 | -1189.72 | -1130.92 | -1087.73 |
Other Equity, Total | 0.186 | 0.177 | 0.114 | 0.087 | 0.182 |
Total Liabilities & Shareholders’ Equity | 527.72 | 588.151 | 265.763 | 277.284 | 284.431 |
Total Common Shares Outstanding | 185.572 | 184.35 | 179.791 | 178.725 | 177.67 |
Long Term Investments | 0 | 6.829 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -184.062 | -182.814 | -108.897 | -101.252 | -65.782 |
Raha majandustegevusest | -142.157 | -135.108 | -89.584 | -92.565 | -41.143 |
Raha majandustegevusest | 0.777 | 0.748 | 0.724 | 0.77 | 0.704 |
Mittelikviidsed varad | 33.004 | 20.083 | 19.461 | 11.447 | 14.608 |
Muutused tööjõus | 8.124 | 26.875 | -0.872 | -3.53 | 9.327 |
Tulu investeeringutelt | 15.804 | -6.856 | 77.934 | 4.768 | -64.642 |
Kapitalikulutused | -2.385 | -0.514 | -0.343 | -0.366 | -0.328 |
Muud rahavood investeeringutelt, kokku | 18.189 | -6.342 | 78.277 | 5.134 | -64.314 |
Rahavood investeeringutelt | 359.668 | 300.589 | 99.098 | 62.504 | 135.703 |
Aktsiate emiteerimine (tagasiost), neto | 65.794 | 110.542 | 79.621 | 56.252 | 135.581 |
Laenu väljastamine (kustutamine), neto | 293.874 | 190.047 | 19.477 | 6.252 | 0.122 |
Rahaline kogumuutus | 233.386 | 158.625 | 87.448 | -25.293 | 29.918 |
Muutused valuutakursside kõikumisest | 0.071 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -74.196 | -184.062 | -166.283 | -107.482 | -64.284 |
Cash From Operating Activities | -77.8 | -142.157 | -109.698 | -86.422 | -61.011 |
Cash From Operating Activities | 0.317 | 0.777 | 0.606 | 0.377 | 0.178 |
Non-Cash Items | 28.634 | 33.004 | 62.615 | 35.809 | 16.52 |
Changes in Working Capital | -32.555 | 8.124 | -6.636 | -15.126 | -13.425 |
Cash From Investing Activities | -38.472 | 15.804 | 26.924 | 19.177 | 14.673 |
Capital Expenditures | -0.406 | -2.385 | -1.277 | -0.912 | -0.099 |
Other Investing Cash Flow Items, Total | -38.066 | 18.189 | 28.201 | 20.089 | 14.772 |
Cash From Financing Activities | 7.356 | 359.668 | 12.25 | 7.474 | 2.9 |
Issuance (Retirement) of Stock, Net | 7.356 | 65.794 | 12.25 | 7.474 | 2.9 |
Net Change in Cash | -108.876 | 233.386 | -70.455 | -59.686 | -43.438 |
Foreign Exchange Effects | 0.04 | 0.071 | 0.069 | 0.085 | |
Issuance (Retirement) of Debt, Net | 293.874 | 0 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.5177 | 14167131 | 359744 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.9264 | 13052882 | 1132849 | 2022-12-31 | LOW |
Baker Bros. Advisors LP | Hedge Fund | 6.7449 | 12710818 | 0 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.9044 | 11126861 | 1722614 | 2022-12-31 | LOW |
Avoro Capital Advisors LLC | Investment Advisor/Hedge Fund | 4.8023 | 9050000 | 0 | 2022-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 3.1084 | 5857788 | 1330751 | 2022-12-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 2.8046 | 5285348 | 471576 | 2022-12-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 2.3513 | 4431114 | -732731 | 2022-12-31 | LOW |
RP Management, LLC | Private Equity | 2.0409 | 3846154 | 0 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8395 | 3466550 | 100706 | 2022-12-31 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 1.5274 | 2878427 | 228811 | 2022-12-31 | LOW |
BNP Paribas Asset Management USA, Inc. | Investment Advisor | 1.4181 | 2672382 | 562718 | 2022-12-31 | LOW |
Assenagon Asset Management S.A. | Investment Advisor | 1.3746 | 2590392 | -25765 | 2022-12-31 | HIGH |
Fairmount Funds Management LLC | Hedge Fund | 1.3495 | 2543107 | 0 | 2022-12-31 | HIGH |
Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.3444 | 2533584 | -986647 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.3185 | 2484819 | -562152 | 2022-12-31 | HIGH |
PFM Health Sciences, LP | Hedge Fund | 1.1475 | 2162411 | 0 | 2022-12-31 | MED |
Woodline Partners LP | Hedge Fund | 1.0989 | 2070983 | 2070983 | 2022-12-31 | HIGH |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.0878 | 2050026 | 2014048 | 2022-12-31 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 1.0552 | 1988627 | 1988627 | 2022-12-31 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BioCryst Company profile
Ettevõttest BioCryst
BioCryst Pharmaceuticals, Inc. (BioCryst) on kommertsjärgus biotehnoloogiaettevõte, mis avastab väikemolekulaarsed ravimid. Ettevõte keskendub haruldaste haiguste suukaudsele ravile, mille puhul on olemas rahuldamata meditsiinilised vajadused ja kus ensüüm mängib haiguse bioloogilises kulgemises võtmerolli. ORLADEYO (berotralstat) on suukaudne, üks kord päevas manustatav ravim, mis on heaks kiidetud Ameerika Ühendriikides, Euroopa Liidus, Jaapanis ja Ühendkuningriigis päriliku angioödeemi (HAE) rünnakute ennetamiseks täiskasvanutel ja 12-aastastel ja vanematel pediaatrilistel patsientidel. BioCrystil on mitu käimasolevat arendusprogrammi, sealhulgas BCX9930, suukaudne D-faktori inhibiitor komplemendi poolt vahendatud haiguste raviks; BCX9250, aktiviiniretseptori sarnase kinaas-2 (ALK-2) inhibiitor fibrodysplasia ossificans progressiva raviks, ja Galidesivir, viirusevastane ravim Marburgi viirushaiguse ja kollapalaviku raviks. RAPIVAB (peramiviiri süsti) on viiruse neuraminidaasi inhibiitor gripi raviks.
Industry: | Bio Therapeutic Drugs |
4505 Emperor Blvd Ste 200
27703-8457
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com